Protocols Directory
Peptide Protocol Directory
Single-compound protocol references with dosing structure, reconstitution math, and evidence context.
Protocol
Tirzepatide
Complete tirzepatide research dosing protocol with phase-by-phase titration schedule (2.5 mg to 15 mg), reconstitution calculator, half-life data, side effects, and clinical trial references. Updated February 2026.
View protocolProtocol
Semaglutide
Complete semaglutide research dosing protocol with phase-by-phase titration schedule (0.25 mg to 2.4 mg), reconstitution calculator, 7-day half-life data, side effects from STEP trials, and NEJM clinical trial references. Updated February 2026.
View protocolProtocol
Retatrutide
Complete retatrutide research dosing protocol with phase-by-phase titration schedule (1mg->12mg), reconstitution calculator, half-life data, side effects, and clinical trial references. Updated February 2026.
View protocolProtocol
Ipamorelin
Complete Ipamorelin research dosing protocol with daily dosage schedule (100-300 mcg), reconstitution calculator, 2-hour half-life data, side effects, and clinical trial references. Updated February 2026.
View protocolProtocol
CJC-1295 No DAC
Complete CJC-1295 No DAC (Mod GRF 1-29) research dosing protocol with daily titration schedule (100-300 mcg), reconstitution calculator, 30-minute half-life data, side effects, and clinical trial references. Updated February 2026.
View protocolProtocol
CJC-1295 with DAC
Complete CJC-1295 with DAC (DAC:GRF) research dosing protocol with weekly injection schedule (1-2 mg), reconstitution calculator, 6-8 day half-life data, side effects, and clinical trial references from JCEM. Updated February 2026.
View protocolProtocol
NAD+
Complete NAD+ injection research dosing protocol with titration schedule (50-100 mg SubQ), reconstitution calculator, side effects, clinical trial references for NR/NMN precursors, and storage guidelines. Updated February 2026.
View protocolProtocol
Sermorelin
Complete Sermorelin research dosing protocol with nightly titration schedule (100-500 mcg), reconstitution calculator, 11-12 minute half-life data, side effects, and clinical references. Updated February 2026.
View protocolProtocol
Tesamorelin
Complete Tesamorelin (Egrifta) research dosing protocol with FDA-approved 2 mg daily dose, reconstitution guide, 26-38 minute half-life data, Phase III clinical trial results (15-20% VAT reduction), side effects, and NAFLD research. Updated February 2026.
View protocolProtocol
BPC-157
Complete BPC-157 research dosing protocol with daily dosage schedule (250-500 mcg), reconstitution calculator, half-life data, side effects, and 30+ years of preclinical research references. Updated February 2026.
View protocolProtocol
TB-500
Complete TB-500 (Thymosin Beta-4) research dosing protocol with loading phase (4-8 mg/week) and maintenance schedule, reconstitution calculator, half-life data, side effects, and Phase II clinical trial references. Updated February 2026.
View protocolProtocol
GHK-Cu
Complete GHK-Cu (copper peptide) research dosing protocol with injectable (1-2 mg daily) and topical schedules, reconstitution calculator, half-life data, gene modulation mechanism, side effects, and clinical trial references. Updated February 2026.
View protocolProtocol
KPV
Complete KPV (Lys-Pro-Val) research dosing protocol with injectable (200-500 mcg daily) and oral administration, anti-inflammatory mechanism via NF-kB inhibition, gut healing evidence, side effects, and preclinical research references. Updated February 2026.
View protocol